ZVRA Q3'26 Earnings: revenue estimate is 37.08M USD

What happened

Zevra Therapeutics will report Q3'26 results on November 03 after the market closes, at 4:05 PM ET. The revenue estimate is 37.08 million USD and the earnings per share estimate is 0.16 USD.

Confirmed

Global impact / market context

Investors will compare actual revenue and profit per share against these estimates. Beating them could support the stock, while missing them could pressure it, because past quarters show results sometimes differed notably from expectations.

Analyst inference

Reported revenue rose across the prior three quarters, and estimates also climbed. This suggests expectations for the business have been improving, raising the bar for the upcoming report.

Analyst inference

What to watch

1. Watch whether reported Q3'26 revenue meets the 37.08 million USD estimate and whether earnings per share meets 0.16 USD. Confirmed
2. Compare the new figures with prior quarters to see whether the rising revenue trend continues, which could shape how investors judge future growth. Proposed
3. A revenue or earnings surprise, similar to past quarters, could shift investor positioning by changing views on the company's earnings outlook. Analyst inference

Evidence

• Original source link unavailable